ANAPTYSBIO, INC Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

ANAPTYSBIO, INC reported Revenue From Contract With Customer Excluding Assessed Tax of $234.60 million for the year ending 2025.

  • ANAPTYSBIO, INC showed an increase of +157.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from ANAPTYSBIO, INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), ANAPTYSBIO, INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 2,246.0%.
  • Historical annual values: Fiscal year 2025: $234.60 million | Fiscal year 2024: $91.28 million | Fiscal year 2023: $17.16 million | Fiscal year 2022: $10.29 million | Fiscal year 2021: $63.18 million | Fiscal year 2020: $75.00 million | Fiscal year 2019: $8.00 million | Fiscal year 2018: $5.00 million | Fiscal year 2017: $10.00 million.
  • Data sourced from SEC EDGAR public filings as of June 25, 2026.

Last verified: